Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockDiscovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1648.35 | 28,301 Cr | 39.22 | 10.11 | 0.00 | 25.77 | 27.45 | 16.91 | ||
4194.05 | 23,881 Cr | 116.04 | 33.02 | 0.07 | 28.46 | 28.75 | 9.13 | ||
1433.00 | 20,237 Cr | 44.49 | 5.54 | 0.00 | 12.45 | 15.31 | 10.29 | ||
39.39 | 18,370 Cr | 19.86 | 1.90 | 0.38 | 9.57 | 12.39 | 7.34 | ||
991.25 | 17,568 Cr | 80.77 | 13.65 | 0.10 | 21.34 | 17.76 | 5.07 | ||
847.10 | 9,415 Cr | 22.00 | 1.66 | 1.89 | 8.48 | 13.05 | 5.56 | ||
427.55 | 9,203 Cr | 128.41 | 5.24 | 0.00 | 4.08 | 5.19 | 3.05 | ||
| Median: 7 Co. | — | 991.25 | 18,370 Cr | 44.49 | 5.54 | 0.07 | 12.45 | 15.31 | 7.34 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Sagility Ltd (SAGILITY) is currently trading at 40.48 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sagility Limited is a technology-enabled healthcare solutions and services provider, offering operations support to both payers and providers in the healthcare sector. The company reported robust financial performance in Q3 FY26, with a revenue of ₹19,712 million, marking a 35.7% year-on-year growth, driven by strong client acquisition and existing client expansion. Sagility's strategic acquisition of BroadPath Healthcare Solutions in 2025 significantly increased its exposure to seasonal open enrollment work, indicating strategic growth in healthcare-focused services. With the acquisition of BirchAI in March 2024, Sagility aims to integrate advanced GenAI technology, reinforcing its competitive edge in healthcare service automation and enhancing operational efficiency. Sagility's commitment to sustainability and corporate responsibility is recognized by earning the EcoVadis Committed Badge, indicating strong ESG performance in its operations.
Over the past 52 weeks, Sagility Ltd has traded between a low of ₹35.82 and a high of ₹57.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sagility Ltd has a market capitalization of approximately 18,369.53. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sagility Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.86 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 18,369.53 Cr, Sagility Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sagility Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sagility Ltd is 19.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The consideration is up to $30 million, with $17.5 million upfront and $12.5 million contingent on future performance.
Sagility India is a tech-enabled BPM company providing services such as claims processing, revenue cycle management, member enrollment, provider data management, and care management for US payers and providers.
Sagility reported Q3 FY26 revenue of ₹19,712 million ($222.0 million), up 35.7% year-on-year from ₹14,531 million.
Elara has set a target price of ₹54, implying about 26% upside from the April 17, 2026 closing price of ₹43 on the NSE.
Bearish
5
Neutral
7
Bullish
2
Bearish
25
Neutral
7
Bullish
14
Bearish
20
Neutral
0
Bullish
12
Sagility Limited is a technology-enabled healthcare solutions and services provider, offering operations support to both payers and providers in the healthcare sector.
The company reported robust financial performance in Q3 FY26, with a revenue of ₹19,712 million, marking a 35.7% year-on-year growth, driven by strong client acquisition and existing client expansion.
Sagility's strategic acquisition of BroadPath Healthcare Solutions in 2025 significantly increased its exposure to seasonal open enrollment work, indicating strategic growth in healthcare-focused services.
With the acquisition of BirchAI in March 2024, Sagility aims to integrate advanced GenAI technology, reinforcing its competitive edge in healthcare service automation and enhancing operational efficiency.
Sagility's commitment to sustainability and corporate responsibility is recognized by earning the EcoVadis Committed Badge, indicating strong ESG performance in its operations.
IT - Services
IT Enabled Services
18,370 Cr
Moderate Risk
19.9
29.2
1.0
1.9
57.90
35.82
Sales CAGR
Profit CAGR
ROE
ROCE
Strategic Acquisition
Sagility has acquired 100% of CareSeed, a U.S. NCQA-certified HEDIS and medical-record review analytics firm (CY25 revenue $5.1M; EBITDA $1.6M), to expand AI-led quality operations, Medicare Advantage/Stars capabilities; deal is EPS-accretive and expected to close June 11, 2026.
Strategic acquisition
Sagility announces 100% acquisition of CareSeed to add NCQA‑certified HEDIS reporting, chart abstraction and analytics, expanding Medicare Advantage quality, Stars capabilities and AI-led quality operations; deal EPS‑accretive, closing June 11, 2026.
Strategic acquisition
Sagility's step‑down subsidiary Sagility LLC signed a definitive agreement on 11 Jun 2026 to acquire CareSeed LLC (US healthcare analytics; CY2025 revenue US$5.1M) for up to US$30M (US$17.5M upfront + up to US$12.5M contingent).
Strategic acquisition
Sagility LLC (step-down subsidiary) signed a definitive agreement on June 11, 2026 to acquire CareSeed LLC (US$5.1M turnover CY2025), an NCQA‑certified HEDIS platform, for up to US$30M cash (US$17.5M upfront + up to US$12.5M contingent) to expand payer analytics and quality/risk‑adjustment capabilities.
